Search results
YS Biopharma to Hold Extraordinary General Meeting on May 21, 2024 and Announces the Appointment of...
KTLA-TV Los Angeles· 3 days agoYS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations ...
NUTEX HEALTH REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS
The Longview News-Journal· 1 day agoTOTAL REVENUE OF $67.5 MILLION FOR FIRST QUARTER 2024 VS $56.3 MILLION IN 2023, AN INCREASE OF 20%HOSPITAL DIVISION VISITS OF 40,068 FOR THE FIRST QUARTER 2024 VS VISITS OF
NCCN Policy Summit Encourages Conversation and Action on Sexual Health and Fertility Issues Faced by...
Newswise· 4 days agoWASHINGTON, D.C. [May 6, 2024] — The National Comprehensive Cancer Network® (NCCN®)—an alliance of...
NCCN Policy Summit Encourages Conversation and Action on Sexual Health and Fertility Issues Faced by...
WJTV Jackson· 4 days agoNational Comprehensive Cancer Network forum examines the impact knowledge gaps, societal stigma, and shifting policies can have on quality of life for people with cancer. WASHINGTON, May 6, ...